nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CYP2C9—Rosuvastatin—atherosclerosis	0.0798	0.154	CbGbCtD
Dorzolamide—CYP2C9—Simvastatin—atherosclerosis	0.0742	0.143	CbGbCtD
Dorzolamide—CYP2C9—Lovastatin—atherosclerosis	0.0726	0.14	CbGbCtD
Dorzolamide—CYP2C9—Pravastatin—atherosclerosis	0.0726	0.14	CbGbCtD
Dorzolamide—CYP3A4—Rosuvastatin—atherosclerosis	0.0464	0.0893	CbGbCtD
Dorzolamide—CYP3A4—Ezetimibe—atherosclerosis	0.0464	0.0893	CbGbCtD
Dorzolamide—CYP3A4—Simvastatin—atherosclerosis	0.0431	0.083	CbGbCtD
Dorzolamide—CYP3A4—Pravastatin—atherosclerosis	0.0422	0.0813	CbGbCtD
Dorzolamide—CYP3A4—Lovastatin—atherosclerosis	0.0422	0.0813	CbGbCtD
Dorzolamide—Erectile dysfunction—Simvastatin—atherosclerosis	0.00134	0.00335	CcSEcCtD
Dorzolamide—Influenza—Niacin—atherosclerosis	0.00134	0.00334	CcSEcCtD
Dorzolamide—Influenza—Pravastatin—atherosclerosis	0.00132	0.00329	CcSEcCtD
Dorzolamide—Arrhythmia—Rosuvastatin—atherosclerosis	0.00132	0.00328	CcSEcCtD
Dorzolamide—Angina pectoris—Niacin—atherosclerosis	0.00131	0.00325	CcSEcCtD
Dorzolamide—Sinusitis—Lovastatin—atherosclerosis	0.00131	0.00325	CcSEcCtD
Dorzolamide—Depression—Simvastatin—atherosclerosis	0.0013	0.00323	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00129	0.00322	CcSEcCtD
Dorzolamide—Bronchitis—Niacin—atherosclerosis	0.00129	0.00321	CcSEcCtD
Dorzolamide—Angina pectoris—Pravastatin—atherosclerosis	0.00129	0.0032	CcSEcCtD
Dorzolamide—Sinusitis—Ezetimibe—atherosclerosis	0.00128	0.00319	CcSEcCtD
Dorzolamide—Erectile dysfunction—Niacin—atherosclerosis	0.00123	0.00308	CcSEcCtD
Dorzolamide—Dysuria—Pravastatin—atherosclerosis	0.00123	0.00308	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Pravastatin—atherosclerosis	0.00123	0.00306	CcSEcCtD
Dorzolamide—Sinusitis—Simvastatin—atherosclerosis	0.00122	0.00304	CcSEcCtD
Dorzolamide—Pharyngitis—Ezetimibe—atherosclerosis	0.00122	0.00303	CcSEcCtD
Dorzolamide—Erectile dysfunction—Pravastatin—atherosclerosis	0.00122	0.00303	CcSEcCtD
Dorzolamide—Weight decreased—Pravastatin—atherosclerosis	0.00119	0.00298	CcSEcCtD
Dorzolamide—Erythema multiforme—Lovastatin—atherosclerosis	0.00118	0.00294	CcSEcCtD
Dorzolamide—Depression—Pravastatin—atherosclerosis	0.00117	0.00292	CcSEcCtD
Dorzolamide—Angioedema—Rosuvastatin—atherosclerosis	0.00117	0.00292	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00117	0.00291	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Pravastatin—atherosclerosis	0.00116	0.00289	CcSEcCtD
Dorzolamide—Erythema multiforme—Ezetimibe—atherosclerosis	0.00116	0.00289	CcSEcCtD
Dorzolamide—Myocardial infarction—Pravastatin—atherosclerosis	0.00115	0.00287	CcSEcCtD
Dorzolamide—Sweating—Niacin—atherosclerosis	0.00115	0.00286	CcSEcCtD
Dorzolamide—Urinary tract infection—Pravastatin—atherosclerosis	0.00114	0.00285	CcSEcCtD
Dorzolamide—Cough—Rosuvastatin—atherosclerosis	0.00112	0.00279	CcSEcCtD
Dorzolamide—Erythema multiforme—Simvastatin—atherosclerosis	0.0011	0.00275	CcSEcCtD
Dorzolamide—Sinusitis—Pravastatin—atherosclerosis	0.0011	0.00275	CcSEcCtD
Dorzolamide—Alopecia—Lovastatin—atherosclerosis	0.0011	0.00275	CcSEcCtD
Dorzolamide—Arthralgia—Rosuvastatin—atherosclerosis	0.00109	0.00272	CcSEcCtD
Dorzolamide—Alopecia—Ezetimibe—atherosclerosis	0.00108	0.0027	CcSEcCtD
Dorzolamide—Erythema—Ezetimibe—atherosclerosis	0.00107	0.00266	CcSEcCtD
Dorzolamide—Dysgeusia—Lovastatin—atherosclerosis	0.00106	0.00265	CcSEcCtD
Dorzolamide—Confusional state—Rosuvastatin—atherosclerosis	0.00106	0.00263	CcSEcCtD
Dorzolamide—Back pain—Lovastatin—atherosclerosis	0.00105	0.00262	CcSEcCtD
Dorzolamide—Pharyngitis—Pravastatin—atherosclerosis	0.00105	0.00261	CcSEcCtD
Dorzolamide—Visual impairment—Niacin—atherosclerosis	0.00103	0.00258	CcSEcCtD
Dorzolamide—Alopecia—Simvastatin—atherosclerosis	0.00103	0.00257	CcSEcCtD
Dorzolamide—Back pain—Ezetimibe—atherosclerosis	0.00103	0.00257	CcSEcCtD
Dorzolamide—Vision blurred—Lovastatin—atherosclerosis	0.00102	0.00255	CcSEcCtD
Dorzolamide—Visual impairment—Pravastatin—atherosclerosis	0.00102	0.00254	CcSEcCtD
Dorzolamide—Erythema—Simvastatin—atherosclerosis	0.00102	0.00253	CcSEcCtD
Dorzolamide—Tinnitus—Niacin—atherosclerosis	0.001	0.00249	CcSEcCtD
Dorzolamide—Erythema multiforme—Pravastatin—atherosclerosis	0.000998	0.00249	CcSEcCtD
Dorzolamide—Dysgeusia—Simvastatin—atherosclerosis	0.000996	0.00248	CcSEcCtD
Dorzolamide—Angioedema—Lovastatin—atherosclerosis	0.000993	0.00248	CcSEcCtD
Dorzolamide—Tinnitus—Pravastatin—atherosclerosis	0.000985	0.00245	CcSEcCtD
Dorzolamide—Vertigo—Lovastatin—atherosclerosis	0.000977	0.00243	CcSEcCtD
Dorzolamide—Angioedema—Ezetimibe—atherosclerosis	0.000974	0.00243	CcSEcCtD
Dorzolamide—Vision blurred—Simvastatin—atherosclerosis	0.000958	0.00239	CcSEcCtD
Dorzolamide—Arrhythmia—Niacin—atherosclerosis	0.000958	0.00239	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000954	0.00238	CcSEcCtD
Dorzolamide—Alopecia—Niacin—atherosclerosis	0.000948	0.00236	CcSEcCtD
Dorzolamide—Insomnia—Rosuvastatin—atherosclerosis	0.000947	0.00236	CcSEcCtD
Dorzolamide—Arrhythmia—Pravastatin—atherosclerosis	0.000943	0.00235	CcSEcCtD
Dorzolamide—Palpitations—Ezetimibe—atherosclerosis	0.000942	0.00235	CcSEcCtD
Dorzolamide—Paraesthesia—Rosuvastatin—atherosclerosis	0.00094	0.00234	CcSEcCtD
Dorzolamide—Erythema—Niacin—atherosclerosis	0.000934	0.00233	CcSEcCtD
Dorzolamide—Alopecia—Pravastatin—atherosclerosis	0.000933	0.00233	CcSEcCtD
Dorzolamide—Cough—Ezetimibe—atherosclerosis	0.00093	0.00232	CcSEcCtD
Dorzolamide—Angioedema—Simvastatin—atherosclerosis	0.000929	0.00232	CcSEcCtD
Dorzolamide—Arthralgia—Lovastatin—atherosclerosis	0.000925	0.00231	CcSEcCtD
Dorzolamide—Chest pain—Lovastatin—atherosclerosis	0.000925	0.00231	CcSEcCtD
Dorzolamide—Anxiety—Lovastatin—atherosclerosis	0.000922	0.0023	CcSEcCtD
Dorzolamide—Dyspepsia—Rosuvastatin—atherosclerosis	0.000922	0.0023	CcSEcCtD
Dorzolamide—Hypertension—Ezetimibe—atherosclerosis	0.000921	0.00229	CcSEcCtD
Dorzolamide—Tension—Niacin—atherosclerosis	0.000916	0.00228	CcSEcCtD
Dorzolamide—Discomfort—Lovastatin—atherosclerosis	0.000914	0.00228	CcSEcCtD
Dorzolamide—Vertigo—Simvastatin—atherosclerosis	0.000914	0.00228	CcSEcCtD
Dorzolamide—Arthralgia—Ezetimibe—atherosclerosis	0.000908	0.00226	CcSEcCtD
Dorzolamide—Chest pain—Ezetimibe—atherosclerosis	0.000908	0.00226	CcSEcCtD
Dorzolamide—Nervousness—Niacin—atherosclerosis	0.000907	0.00226	CcSEcCtD
Dorzolamide—Dry mouth—Lovastatin—atherosclerosis	0.000905	0.00226	CcSEcCtD
Dorzolamide—Tension—Pravastatin—atherosclerosis	0.000902	0.00225	CcSEcCtD
Dorzolamide—Dysgeusia—Pravastatin—atherosclerosis	0.0009	0.00224	CcSEcCtD
Dorzolamide—Discomfort—Ezetimibe—atherosclerosis	0.000897	0.00224	CcSEcCtD
Dorzolamide—Pain—Rosuvastatin—atherosclerosis	0.000895	0.00223	CcSEcCtD
Dorzolamide—Confusional state—Lovastatin—atherosclerosis	0.000895	0.00223	CcSEcCtD
Dorzolamide—Nervousness—Pravastatin—atherosclerosis	0.000893	0.00223	CcSEcCtD
Dorzolamide—Dry mouth—Ezetimibe—atherosclerosis	0.000888	0.00221	CcSEcCtD
Dorzolamide—Anaphylactic shock—Lovastatin—atherosclerosis	0.000887	0.00221	CcSEcCtD
Dorzolamide—Vision blurred—Niacin—atherosclerosis	0.00088	0.00219	CcSEcCtD
Dorzolamide—Confusional state—Ezetimibe—atherosclerosis	0.000877	0.00219	CcSEcCtD
Dorzolamide—Anaphylactic shock—Ezetimibe—atherosclerosis	0.00087	0.00217	CcSEcCtD
Dorzolamide—Vision blurred—Pravastatin—atherosclerosis	0.000866	0.00216	CcSEcCtD
Dorzolamide—Arthralgia—Simvastatin—atherosclerosis	0.000866	0.00216	CcSEcCtD
Dorzolamide—Chest pain—Simvastatin—atherosclerosis	0.000866	0.00216	CcSEcCtD
Dorzolamide—Feeling abnormal—Rosuvastatin—atherosclerosis	0.000863	0.00215	CcSEcCtD
Dorzolamide—Anxiety—Simvastatin—atherosclerosis	0.000863	0.00215	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000856	0.00213	CcSEcCtD
Dorzolamide—Discomfort—Simvastatin—atherosclerosis	0.000855	0.00213	CcSEcCtD
Dorzolamide—Angioedema—Niacin—atherosclerosis	0.000853	0.00213	CcSEcCtD
Dorzolamide—Anorexia—Lovastatin—atherosclerosis	0.000846	0.00211	CcSEcCtD
Dorzolamide—Angioedema—Pravastatin—atherosclerosis	0.00084	0.00209	CcSEcCtD
Dorzolamide—Vertigo—Niacin—atherosclerosis	0.000839	0.00209	CcSEcCtD
Dorzolamide—Syncope—Niacin—atherosclerosis	0.000837	0.00209	CcSEcCtD
Dorzolamide—Confusional state—Simvastatin—atherosclerosis	0.000837	0.00209	CcSEcCtD
Dorzolamide—Urticaria—Rosuvastatin—atherosclerosis	0.000832	0.00207	CcSEcCtD
Dorzolamide—Anaphylactic shock—Simvastatin—atherosclerosis	0.00083	0.00207	CcSEcCtD
Dorzolamide—Oedema—Simvastatin—atherosclerosis	0.00083	0.00207	CcSEcCtD
Dorzolamide—Abdominal pain—Rosuvastatin—atherosclerosis	0.000828	0.00206	CcSEcCtD
Dorzolamide—Vertigo—Pravastatin—atherosclerosis	0.000826	0.00206	CcSEcCtD
Dorzolamide—Palpitations—Niacin—atherosclerosis	0.000825	0.00206	CcSEcCtD
Dorzolamide—Loss of consciousness—Niacin—atherosclerosis	0.000821	0.00205	CcSEcCtD
Dorzolamide—Cough—Niacin—atherosclerosis	0.000815	0.00203	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000808	0.00201	CcSEcCtD
Dorzolamide—Insomnia—Lovastatin—atherosclerosis	0.000802	0.002	CcSEcCtD
Dorzolamide—Cough—Pravastatin—atherosclerosis	0.000802	0.002	CcSEcCtD
Dorzolamide—Paraesthesia—Lovastatin—atherosclerosis	0.000797	0.00199	CcSEcCtD
Dorzolamide—Arthralgia—Niacin—atherosclerosis	0.000795	0.00198	CcSEcCtD
Dorzolamide—Hypertension—Pravastatin—atherosclerosis	0.000794	0.00198	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000793	0.00198	CcSEcCtD
Dorzolamide—Anorexia—Simvastatin—atherosclerosis	0.000791	0.00197	CcSEcCtD
Dorzolamide—Dyspnoea—Lovastatin—atherosclerosis	0.000791	0.00197	CcSEcCtD
Dorzolamide—Insomnia—Ezetimibe—atherosclerosis	0.000787	0.00196	CcSEcCtD
Dorzolamide—Chest pain—Pravastatin—atherosclerosis	0.000783	0.00195	CcSEcCtD
Dorzolamide—Arthralgia—Pravastatin—atherosclerosis	0.000783	0.00195	CcSEcCtD
Dorzolamide—Paraesthesia—Ezetimibe—atherosclerosis	0.000781	0.00195	CcSEcCtD
Dorzolamide—Dyspepsia—Lovastatin—atherosclerosis	0.000781	0.00195	CcSEcCtD
Dorzolamide—Anxiety—Pravastatin—atherosclerosis	0.00078	0.00194	CcSEcCtD
Dorzolamide—Dry mouth—Niacin—atherosclerosis	0.000777	0.00194	CcSEcCtD
Dorzolamide—Dyspnoea—Ezetimibe—atherosclerosis	0.000776	0.00193	CcSEcCtD
Dorzolamide—Discomfort—Pravastatin—atherosclerosis	0.000773	0.00193	CcSEcCtD
Dorzolamide—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000771	0.00192	CcSEcCtD
Dorzolamide—Decreased appetite—Lovastatin—atherosclerosis	0.000771	0.00192	CcSEcCtD
Dorzolamide—Dyspepsia—Ezetimibe—atherosclerosis	0.000766	0.00191	CcSEcCtD
Dorzolamide—Fatigue—Lovastatin—atherosclerosis	0.000765	0.00191	CcSEcCtD
Dorzolamide—Oedema—Niacin—atherosclerosis	0.000762	0.0019	CcSEcCtD
Dorzolamide—Anaphylactic shock—Niacin—atherosclerosis	0.000762	0.0019	CcSEcCtD
Dorzolamide—Pain—Lovastatin—atherosclerosis	0.000759	0.00189	CcSEcCtD
Dorzolamide—Confusional state—Pravastatin—atherosclerosis	0.000756	0.00189	CcSEcCtD
Dorzolamide—Decreased appetite—Ezetimibe—atherosclerosis	0.000756	0.00189	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000756	0.00188	CcSEcCtD
Dorzolamide—Asthenia—Rosuvastatin—atherosclerosis	0.000751	0.00187	CcSEcCtD
Dorzolamide—Insomnia—Simvastatin—atherosclerosis	0.000751	0.00187	CcSEcCtD
Dorzolamide—Anaphylactic shock—Pravastatin—atherosclerosis	0.00075	0.00187	CcSEcCtD
Dorzolamide—Oedema—Pravastatin—atherosclerosis	0.00075	0.00187	CcSEcCtD
Dorzolamide—Fatigue—Ezetimibe—atherosclerosis	0.00075	0.00187	CcSEcCtD
Dorzolamide—Shock—Niacin—atherosclerosis	0.00075	0.00187	CcSEcCtD
Dorzolamide—Paraesthesia—Simvastatin—atherosclerosis	0.000745	0.00186	CcSEcCtD
Dorzolamide—Pain—Ezetimibe—atherosclerosis	0.000744	0.00186	CcSEcCtD
Dorzolamide—Pruritus—Rosuvastatin—atherosclerosis	0.000741	0.00185	CcSEcCtD
Dorzolamide—Dyspnoea—Simvastatin—atherosclerosis	0.00074	0.00184	CcSEcCtD
Dorzolamide—Hyperhidrosis—Niacin—atherosclerosis	0.000737	0.00184	CcSEcCtD
Dorzolamide—Feeling abnormal—Lovastatin—atherosclerosis	0.000731	0.00182	CcSEcCtD
Dorzolamide—Dyspepsia—Simvastatin—atherosclerosis	0.00073	0.00182	CcSEcCtD
Dorzolamide—Anorexia—Niacin—atherosclerosis	0.000726	0.00181	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000725	0.00181	CcSEcCtD
Dorzolamide—Hyperhidrosis—Pravastatin—atherosclerosis	0.000725	0.00181	CcSEcCtD
Dorzolamide—Decreased appetite—Simvastatin—atherosclerosis	0.000721	0.0018	CcSEcCtD
Dorzolamide—Feeling abnormal—Ezetimibe—atherosclerosis	0.000717	0.00179	CcSEcCtD
Dorzolamide—Diarrhoea—Rosuvastatin—atherosclerosis	0.000716	0.00179	CcSEcCtD
Dorzolamide—Fatigue—Simvastatin—atherosclerosis	0.000715	0.00178	CcSEcCtD
Dorzolamide—Anorexia—Pravastatin—atherosclerosis	0.000715	0.00178	CcSEcCtD
Dorzolamide—Hypotension—Niacin—atherosclerosis	0.000712	0.00177	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000712	0.00177	CcSEcCtD
Dorzolamide—Pain—Simvastatin—atherosclerosis	0.00071	0.00177	CcSEcCtD
Dorzolamide—Urticaria—Lovastatin—atherosclerosis	0.000705	0.00176	CcSEcCtD
Dorzolamide—Abdominal pain—Lovastatin—atherosclerosis	0.000701	0.00175	CcSEcCtD
Dorzolamide—Body temperature increased—Lovastatin—atherosclerosis	0.000701	0.00175	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000694	0.00173	CcSEcCtD
Dorzolamide—Dizziness—Rosuvastatin—atherosclerosis	0.000692	0.00173	CcSEcCtD
Dorzolamide—Urticaria—Ezetimibe—atherosclerosis	0.000691	0.00172	CcSEcCtD
Dorzolamide—Insomnia—Niacin—atherosclerosis	0.000689	0.00172	CcSEcCtD
Dorzolamide—Body temperature increased—Ezetimibe—atherosclerosis	0.000688	0.00171	CcSEcCtD
Dorzolamide—Abdominal pain—Ezetimibe—atherosclerosis	0.000688	0.00171	CcSEcCtD
Dorzolamide—Paraesthesia—Niacin—atherosclerosis	0.000684	0.00171	CcSEcCtD
Dorzolamide—Feeling abnormal—Simvastatin—atherosclerosis	0.000684	0.0017	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000684	0.0017	CcSEcCtD
Dorzolamide—Dyspnoea—Niacin—atherosclerosis	0.000679	0.00169	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000679	0.00169	CcSEcCtD
Dorzolamide—Insomnia—Pravastatin—atherosclerosis	0.000679	0.00169	CcSEcCtD
Dorzolamide—Somnolence—Niacin—atherosclerosis	0.000677	0.00169	CcSEcCtD
Dorzolamide—Paraesthesia—Pravastatin—atherosclerosis	0.000674	0.00168	CcSEcCtD
Dorzolamide—Dyspepsia—Niacin—atherosclerosis	0.000671	0.00167	CcSEcCtD
Dorzolamide—Dyspnoea—Pravastatin—atherosclerosis	0.000669	0.00167	CcSEcCtD
Dorzolamide—Decreased appetite—Niacin—atherosclerosis	0.000662	0.00165	CcSEcCtD
Dorzolamide—Dyspepsia—Pravastatin—atherosclerosis	0.00066	0.00165	CcSEcCtD
Dorzolamide—Rash—Rosuvastatin—atherosclerosis	0.00066	0.00165	CcSEcCtD
Dorzolamide—Dermatitis—Rosuvastatin—atherosclerosis	0.000659	0.00164	CcSEcCtD
Dorzolamide—Urticaria—Simvastatin—atherosclerosis	0.000659	0.00164	CcSEcCtD
Dorzolamide—Abdominal pain—Simvastatin—atherosclerosis	0.000656	0.00164	CcSEcCtD
Dorzolamide—Body temperature increased—Simvastatin—atherosclerosis	0.000656	0.00164	CcSEcCtD
Dorzolamide—Headache—Rosuvastatin—atherosclerosis	0.000656	0.00163	CcSEcCtD
Dorzolamide—Hypersensitivity—Lovastatin—atherosclerosis	0.000654	0.00163	CcSEcCtD
Dorzolamide—Decreased appetite—Pravastatin—atherosclerosis	0.000652	0.00163	CcSEcCtD
Dorzolamide—Pain—Niacin—atherosclerosis	0.000652	0.00162	CcSEcCtD
Dorzolamide—Fatigue—Pravastatin—atherosclerosis	0.000647	0.00161	CcSEcCtD
Dorzolamide—Pain—Pravastatin—atherosclerosis	0.000642	0.0016	CcSEcCtD
Dorzolamide—Hypersensitivity—Ezetimibe—atherosclerosis	0.000641	0.0016	CcSEcCtD
Dorzolamide—Asthenia—Lovastatin—atherosclerosis	0.000637	0.00159	CcSEcCtD
Dorzolamide—Pruritus—Lovastatin—atherosclerosis	0.000628	0.00156	CcSEcCtD
Dorzolamide—Asthenia—Ezetimibe—atherosclerosis	0.000624	0.00156	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Niacin—atherosclerosis	0.000623	0.00155	CcSEcCtD
Dorzolamide—Nausea—Rosuvastatin—atherosclerosis	0.000622	0.00155	CcSEcCtD
Dorzolamide—Feeling abnormal—Pravastatin—atherosclerosis	0.000618	0.00154	CcSEcCtD
Dorzolamide—Pruritus—Ezetimibe—atherosclerosis	0.000616	0.00153	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000613	0.00153	CcSEcCtD
Dorzolamide—Hypersensitivity—Simvastatin—atherosclerosis	0.000611	0.00152	CcSEcCtD
Dorzolamide—Diarrhoea—Lovastatin—atherosclerosis	0.000607	0.00151	CcSEcCtD
Dorzolamide—Urticaria—Niacin—atherosclerosis	0.000605	0.00151	CcSEcCtD
Dorzolamide—Abdominal pain—Niacin—atherosclerosis	0.000602	0.0015	CcSEcCtD
Dorzolamide—Body temperature increased—Niacin—atherosclerosis	0.000602	0.0015	CcSEcCtD
Dorzolamide—Urticaria—Pravastatin—atherosclerosis	0.000596	0.00149	CcSEcCtD
Dorzolamide—Asthenia—Simvastatin—atherosclerosis	0.000595	0.00148	CcSEcCtD
Dorzolamide—Diarrhoea—Ezetimibe—atherosclerosis	0.000595	0.00148	CcSEcCtD
Dorzolamide—Body temperature increased—Pravastatin—atherosclerosis	0.000593	0.00148	CcSEcCtD
Dorzolamide—Abdominal pain—Pravastatin—atherosclerosis	0.000593	0.00148	CcSEcCtD
Dorzolamide—Pruritus—Simvastatin—atherosclerosis	0.000587	0.00146	CcSEcCtD
Dorzolamide—Dizziness—Lovastatin—atherosclerosis	0.000587	0.00146	CcSEcCtD
Dorzolamide—Dizziness—Ezetimibe—atherosclerosis	0.000575	0.00143	CcSEcCtD
Dorzolamide—Diarrhoea—Simvastatin—atherosclerosis	0.000568	0.00142	CcSEcCtD
Dorzolamide—Vomiting—Lovastatin—atherosclerosis	0.000564	0.00141	CcSEcCtD
Dorzolamide—Hypersensitivity—Niacin—atherosclerosis	0.000561	0.0014	CcSEcCtD
Dorzolamide—Rash—Lovastatin—atherosclerosis	0.000559	0.00139	CcSEcCtD
Dorzolamide—Dermatitis—Lovastatin—atherosclerosis	0.000559	0.00139	CcSEcCtD
Dorzolamide—Headache—Lovastatin—atherosclerosis	0.000556	0.00139	CcSEcCtD
Dorzolamide—Vomiting—Ezetimibe—atherosclerosis	0.000553	0.00138	CcSEcCtD
Dorzolamide—Hypersensitivity—Pravastatin—atherosclerosis	0.000553	0.00138	CcSEcCtD
Dorzolamide—Dizziness—Simvastatin—atherosclerosis	0.000549	0.00137	CcSEcCtD
Dorzolamide—Rash—Ezetimibe—atherosclerosis	0.000549	0.00137	CcSEcCtD
Dorzolamide—Dermatitis—Ezetimibe—atherosclerosis	0.000548	0.00137	CcSEcCtD
Dorzolamide—Asthenia—Niacin—atherosclerosis	0.000547	0.00136	CcSEcCtD
Dorzolamide—Headache—Ezetimibe—atherosclerosis	0.000545	0.00136	CcSEcCtD
Dorzolamide—Pruritus—Niacin—atherosclerosis	0.000539	0.00134	CcSEcCtD
Dorzolamide—Asthenia—Pravastatin—atherosclerosis	0.000538	0.00134	CcSEcCtD
Dorzolamide—Pruritus—Pravastatin—atherosclerosis	0.000531	0.00132	CcSEcCtD
Dorzolamide—Vomiting—Simvastatin—atherosclerosis	0.000528	0.00132	CcSEcCtD
Dorzolamide—Nausea—Lovastatin—atherosclerosis	0.000527	0.00131	CcSEcCtD
Dorzolamide—Rash—Simvastatin—atherosclerosis	0.000523	0.0013	CcSEcCtD
Dorzolamide—Dermatitis—Simvastatin—atherosclerosis	0.000523	0.0013	CcSEcCtD
Dorzolamide—Diarrhoea—Niacin—atherosclerosis	0.000521	0.0013	CcSEcCtD
Dorzolamide—Headache—Simvastatin—atherosclerosis	0.00052	0.0013	CcSEcCtD
Dorzolamide—Nausea—Ezetimibe—atherosclerosis	0.000517	0.00129	CcSEcCtD
Dorzolamide—Diarrhoea—Pravastatin—atherosclerosis	0.000513	0.00128	CcSEcCtD
Dorzolamide—Dizziness—Niacin—atherosclerosis	0.000504	0.00126	CcSEcCtD
Dorzolamide—Dizziness—Pravastatin—atherosclerosis	0.000496	0.00124	CcSEcCtD
Dorzolamide—Nausea—Simvastatin—atherosclerosis	0.000493	0.00123	CcSEcCtD
Dorzolamide—Vomiting—Niacin—atherosclerosis	0.000484	0.00121	CcSEcCtD
Dorzolamide—Rash—Niacin—atherosclerosis	0.00048	0.0012	CcSEcCtD
Dorzolamide—Dermatitis—Niacin—atherosclerosis	0.00048	0.0012	CcSEcCtD
Dorzolamide—Headache—Niacin—atherosclerosis	0.000477	0.00119	CcSEcCtD
Dorzolamide—Vomiting—Pravastatin—atherosclerosis	0.000477	0.00119	CcSEcCtD
Dorzolamide—Rash—Pravastatin—atherosclerosis	0.000473	0.00118	CcSEcCtD
Dorzolamide—Dermatitis—Pravastatin—atherosclerosis	0.000473	0.00118	CcSEcCtD
Dorzolamide—Headache—Pravastatin—atherosclerosis	0.00047	0.00117	CcSEcCtD
Dorzolamide—Nausea—Niacin—atherosclerosis	0.000453	0.00113	CcSEcCtD
Dorzolamide—Nausea—Pravastatin—atherosclerosis	0.000446	0.00111	CcSEcCtD
Dorzolamide—CA12—Metabolism—PPARA—atherosclerosis	5.81e-05	0.000733	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PIK3CG—atherosclerosis	5.75e-05	0.000726	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PIK3CG—atherosclerosis	5.75e-05	0.000726	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—HMOX1—atherosclerosis	5.73e-05	0.000724	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PPARG—atherosclerosis	5.69e-05	0.000719	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AGT—atherosclerosis	5.62e-05	0.00071	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—INS—atherosclerosis	5.58e-05	0.000705	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PPARG—atherosclerosis	5.55e-05	0.000701	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PPARG—atherosclerosis	5.55e-05	0.000701	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP27A1—atherosclerosis	5.54e-05	0.000699	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—APOE—atherosclerosis	5.51e-05	0.000696	CbGpPWpGaD
Dorzolamide—CA9—Cellular responses to stress—IL6—atherosclerosis	5.5e-05	0.000694	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—HMOX1—atherosclerosis	5.49e-05	0.000694	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—APOB—atherosclerosis	5.49e-05	0.000693	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—CAV1—atherosclerosis	5.46e-05	0.000689	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—APOA1—atherosclerosis	5.45e-05	0.000688	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—INS—atherosclerosis	5.44e-05	0.000687	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—INS—atherosclerosis	5.44e-05	0.000687	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ABCA1—atherosclerosis	5.4e-05	0.000681	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PIK3CG—atherosclerosis	5.37e-05	0.000678	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PIK3CG—atherosclerosis	5.37e-05	0.000678	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GSTM1—atherosclerosis	5.34e-05	0.000674	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—HMOX1—atherosclerosis	5.27e-05	0.000665	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—APOB—atherosclerosis	5.26e-05	0.000664	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5AP—atherosclerosis	5.25e-05	0.000663	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA2—atherosclerosis	5.25e-05	0.000663	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX15—atherosclerosis	5.25e-05	0.000663	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G2A—atherosclerosis	5.25e-05	0.000663	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—LPL—atherosclerosis	5.24e-05	0.000662	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCG5—atherosclerosis	5.18e-05	0.000655	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PPARG—atherosclerosis	5.18e-05	0.000654	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PPARG—atherosclerosis	5.18e-05	0.000654	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GSTM1—atherosclerosis	5.12e-05	0.000646	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—ALB—atherosclerosis	5.12e-05	0.000646	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—GPX1—atherosclerosis	5.11e-05	0.000646	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—INS—atherosclerosis	5.08e-05	0.000641	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—INS—atherosclerosis	5.08e-05	0.000641	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—APOB—atherosclerosis	5.05e-05	0.000637	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—LPL—atherosclerosis	5.03e-05	0.000634	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—LPA—atherosclerosis	5.01e-05	0.000632	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—ALB—atherosclerosis	4.99e-05	0.00063	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—ALB—atherosclerosis	4.99e-05	0.00063	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CD36—atherosclerosis	4.98e-05	0.000629	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PIK3CG—atherosclerosis	4.97e-05	0.000628	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GSTM1—atherosclerosis	4.91e-05	0.00062	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—GPX1—atherosclerosis	4.9e-05	0.000619	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—NOS3—atherosclerosis	4.9e-05	0.000618	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—LPL—atherosclerosis	4.82e-05	0.000608	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA5—atherosclerosis	4.8e-05	0.000606	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PPARG—atherosclerosis	4.8e-05	0.000606	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CD36—atherosclerosis	4.77e-05	0.000603	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—NOS3—atherosclerosis	4.77e-05	0.000603	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—NOS3—atherosclerosis	4.77e-05	0.000603	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—MTHFR—atherosclerosis	4.72e-05	0.000596	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—INS—atherosclerosis	4.71e-05	0.000594	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—GPX1—atherosclerosis	4.7e-05	0.000593	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—ALB—atherosclerosis	4.66e-05	0.000588	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—ALB—atherosclerosis	4.66e-05	0.000588	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—HMOX1—atherosclerosis	4.63e-05	0.000585	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PPARA—atherosclerosis	4.63e-05	0.000585	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PLA2G1B—atherosclerosis	4.62e-05	0.000583	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CD36—atherosclerosis	4.58e-05	0.000578	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LDLRAP1—atherosclerosis	4.57e-05	0.000577	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—MTHFR—atherosclerosis	4.52e-05	0.000571	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AGT—atherosclerosis	4.48e-05	0.000566	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—PTGS2—atherosclerosis	4.48e-05	0.000565	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALOX5—atherosclerosis	4.46e-05	0.000564	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—NOS3—atherosclerosis	4.46e-05	0.000563	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—NOS3—atherosclerosis	4.46e-05	0.000563	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PPARA—atherosclerosis	4.44e-05	0.00056	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—APOB—atherosclerosis	4.44e-05	0.00056	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—APOE—atherosclerosis	4.39e-05	0.000555	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—PTGS2—atherosclerosis	4.36e-05	0.000551	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—PTGS2—atherosclerosis	4.36e-05	0.000551	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—CAV1—atherosclerosis	4.35e-05	0.00055	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—APOA1—atherosclerosis	4.34e-05	0.000548	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—MTHFR—atherosclerosis	4.34e-05	0.000548	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GSTM1—atherosclerosis	4.31e-05	0.000545	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—ALB—atherosclerosis	4.31e-05	0.000545	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AGT—atherosclerosis	4.3e-05	0.000543	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLTP—atherosclerosis	4.29e-05	0.000542	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PPARA—atherosclerosis	4.26e-05	0.000537	CbGpPWpGaD
Dorzolamide—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	4.25e-05	0.000536	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—LPL—atherosclerosis	4.24e-05	0.000535	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—APOE—atherosclerosis	4.21e-05	0.000532	CbGpPWpGaD
Dorzolamide—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	4.19e-05	0.000529	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—CAV1—atherosclerosis	4.17e-05	0.000527	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—APOA1—atherosclerosis	4.16e-05	0.000526	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—GPX1—atherosclerosis	4.13e-05	0.000522	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—NOS3—atherosclerosis	4.13e-05	0.000521	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AGT—atherosclerosis	4.12e-05	0.00052	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—PTGS2—atherosclerosis	4.07e-05	0.000514	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—PTGS2—atherosclerosis	4.07e-05	0.000514	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—APOE—atherosclerosis	4.04e-05	0.00051	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CD36—atherosclerosis	4.02e-05	0.000508	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—CAV1—atherosclerosis	4e-05	0.000505	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—APOA1—atherosclerosis	3.99e-05	0.000504	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—LIPC—atherosclerosis	3.98e-05	0.000502	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PIK3CG—atherosclerosis	3.97e-05	0.000501	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—atherosclerosis	3.95e-05	0.000499	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—LDLR—atherosclerosis	3.93e-05	0.000496	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CETP—atherosclerosis	3.84e-05	0.000485	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PPARG—atherosclerosis	3.83e-05	0.000483	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—MTHFR—atherosclerosis	3.81e-05	0.000481	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PIK3CG—atherosclerosis	3.8e-05	0.00048	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—PTGS2—atherosclerosis	3.78e-05	0.000477	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—INS—atherosclerosis	3.75e-05	0.000474	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PPARA—atherosclerosis	3.74e-05	0.000472	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LTA4H—atherosclerosis	3.72e-05	0.00047	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCG8—atherosclerosis	3.72e-05	0.00047	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—atherosclerosis	3.68e-05	0.000464	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PPARG—atherosclerosis	3.67e-05	0.000463	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PIK3CG—atherosclerosis	3.64e-05	0.00046	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AGT—atherosclerosis	3.62e-05	0.000457	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—INS—atherosclerosis	3.6e-05	0.000454	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—APOE—atherosclerosis	3.55e-05	0.000448	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—CAV1—atherosclerosis	3.52e-05	0.000444	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PPARG—atherosclerosis	3.52e-05	0.000444	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—APOA1—atherosclerosis	3.51e-05	0.000443	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—HMGCR—atherosclerosis	3.47e-05	0.000438	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—INS—atherosclerosis	3.45e-05	0.000436	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—ALB—atherosclerosis	3.44e-05	0.000434	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—ALB—atherosclerosis	3.3e-05	0.000417	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—NOS3—atherosclerosis	3.29e-05	0.000416	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PIK3CG—atherosclerosis	3.2e-05	0.000405	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—ALB—atherosclerosis	3.16e-05	0.000399	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—NOS3—atherosclerosis	3.16e-05	0.000398	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ABCA1—atherosclerosis	3.09e-05	0.000391	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PPARG—atherosclerosis	3.09e-05	0.00039	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—INS—atherosclerosis	3.03e-05	0.000383	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—NOS3—atherosclerosis	3.03e-05	0.000382	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	3.01e-05	0.00038	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—PTGS2—atherosclerosis	3.01e-05	0.00038	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCG1—atherosclerosis	2.94e-05	0.000372	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—PTGS2—atherosclerosis	2.89e-05	0.000364	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLTP—atherosclerosis	2.83e-05	0.000358	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—ALB—atherosclerosis	2.78e-05	0.000351	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—PTGS2—atherosclerosis	2.77e-05	0.000349	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—FABP4—atherosclerosis	2.77e-05	0.000349	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LCAT—atherosclerosis	2.77e-05	0.000349	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOA4—atherosclerosis	2.72e-05	0.000343	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP7A1—atherosclerosis	2.67e-05	0.000337	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—NOS3—atherosclerosis	2.66e-05	0.000336	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	2.54e-05	0.000321	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CYP27A1—atherosclerosis	2.47e-05	0.000311	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCG8—atherosclerosis	2.46e-05	0.00031	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LTA4H—atherosclerosis	2.46e-05	0.00031	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—PTGS2—atherosclerosis	2.43e-05	0.000307	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	2.43e-05	0.000307	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	2.37e-05	0.000299	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLA2G2A—atherosclerosis	2.34e-05	0.000295	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOA2—atherosclerosis	2.34e-05	0.000295	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALOX5AP—atherosclerosis	2.34e-05	0.000295	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALOX15—atherosclerosis	2.34e-05	0.000295	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCG5—atherosclerosis	2.31e-05	0.000292	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	2.31e-05	0.000291	CbGpPWpGaD
Dorzolamide—CA14—Metabolism—AKT1—atherosclerosis	2.25e-05	0.000284	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LPA—atherosclerosis	2.23e-05	0.000282	CbGpPWpGaD
Dorzolamide—CA6—Metabolism—AKT1—atherosclerosis	2.19e-05	0.000277	CbGpPWpGaD
Dorzolamide—CA5A—Metabolism—AKT1—atherosclerosis	2.19e-05	0.000277	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—BGN—atherosclerosis	2.16e-05	0.000273	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	2.14e-05	0.000271	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOA5—atherosclerosis	2.14e-05	0.00027	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	2.08e-05	0.000262	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PLA2G1B—atherosclerosis	2.06e-05	0.00026	CbGpPWpGaD
Dorzolamide—CA5B—Metabolism—AKT1—atherosclerosis	2.05e-05	0.000259	CbGpPWpGaD
Dorzolamide—CA7—Metabolism—AKT1—atherosclerosis	2.05e-05	0.000259	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	2.03e-05	0.000257	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	2.02e-05	0.000255	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	2.01e-05	0.000254	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALOX5—atherosclerosis	1.99e-05	0.000251	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCG1—atherosclerosis	1.94e-05	0.000245	CbGpPWpGaD
Dorzolamide—CA12—Metabolism—AKT1—atherosclerosis	1.9e-05	0.00024	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	1.84e-05	0.000232	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—FABP4—atherosclerosis	1.82e-05	0.00023	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LCAT—atherosclerosis	1.82e-05	0.00023	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOA4—atherosclerosis	1.79e-05	0.000226	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NAMPT—atherosclerosis	1.78e-05	0.000225	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	1.77e-05	0.000224	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LIPC—atherosclerosis	1.77e-05	0.000224	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOC3—atherosclerosis	1.76e-05	0.000222	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP7A1—atherosclerosis	1.76e-05	0.000222	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LDLR—atherosclerosis	1.75e-05	0.000221	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CETP—atherosclerosis	1.71e-05	0.000216	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—SCARB1—atherosclerosis	1.64e-05	0.000207	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CYP27A1—atherosclerosis	1.63e-05	0.000205	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	1.59e-05	0.000201	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMGCR—atherosclerosis	1.55e-05	0.000195	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOA2—atherosclerosis	1.54e-05	0.000195	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	1.54e-05	0.000195	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALOX15—atherosclerosis	1.54e-05	0.000195	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	1.54e-05	0.000195	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCG5—atherosclerosis	1.52e-05	0.000192	CbGpPWpGaD
Dorzolamide—CA4—Metabolism—AKT1—atherosclerosis	1.51e-05	0.000191	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LPA—atherosclerosis	1.47e-05	0.000186	CbGpPWpGaD
Dorzolamide—CA2—Metabolism—AKT1—atherosclerosis	1.45e-05	0.000183	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—BGN—atherosclerosis	1.42e-05	0.00018	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOA5—atherosclerosis	1.41e-05	0.000178	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	1.39e-05	0.000176	CbGpPWpGaD
Dorzolamide—CA1—Metabolism—AKT1—atherosclerosis	1.39e-05	0.000176	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ABCA1—atherosclerosis	1.38e-05	0.000174	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	1.36e-05	0.000171	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALOX5—atherosclerosis	1.31e-05	0.000166	CbGpPWpGaD
Dorzolamide—CA9—Metabolism—AKT1—atherosclerosis	1.22e-05	0.000154	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—HMOX1—atherosclerosis	1.18e-05	0.000149	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NAMPT—atherosclerosis	1.18e-05	0.000148	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LIPC—atherosclerosis	1.17e-05	0.000148	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOC3—atherosclerosis	1.16e-05	0.000147	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LDLR—atherosclerosis	1.15e-05	0.000146	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOB—atherosclerosis	1.13e-05	0.000143	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CETP—atherosclerosis	1.13e-05	0.000142	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GSTM1—atherosclerosis	1.1e-05	0.000139	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—LPL—atherosclerosis	1.08e-05	0.000137	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—SCARB1—atherosclerosis	1.08e-05	0.000136	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—GPX1—atherosclerosis	1.05e-05	0.000133	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CD36—atherosclerosis	1.03e-05	0.00013	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMGCR—atherosclerosis	1.02e-05	0.000129	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—MTHFR—atherosclerosis	9.73e-06	0.000123	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARA—atherosclerosis	9.55e-06	0.000121	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AGT—atherosclerosis	9.25e-06	0.000117	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ABCA1—atherosclerosis	9.09e-06	0.000115	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOE—atherosclerosis	9.06e-06	0.000114	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—CAV1—atherosclerosis	8.98e-06	0.000113	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—APOA1—atherosclerosis	8.96e-06	0.000113	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PIK3CG—atherosclerosis	8.18e-06	0.000103	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PPARG—atherosclerosis	7.89e-06	9.97e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—HMOX1—atherosclerosis	7.8e-06	9.84e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—INS—atherosclerosis	7.74e-06	9.77e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOB—atherosclerosis	7.47e-06	9.43e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GSTM1—atherosclerosis	7.26e-06	9.17e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—LPL—atherosclerosis	7.13e-06	9e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—ALB—atherosclerosis	7.1e-06	8.96e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—GPX1—atherosclerosis	6.96e-06	8.78e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—NOS3—atherosclerosis	6.79e-06	8.57e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CD36—atherosclerosis	6.77e-06	8.55e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—MTHFR—atherosclerosis	6.42e-06	8.11e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARA—atherosclerosis	6.3e-06	7.95e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—PTGS2—atherosclerosis	6.21e-06	7.84e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AGT—atherosclerosis	6.1e-06	7.7e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOE—atherosclerosis	5.98e-06	7.55e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—CAV1—atherosclerosis	5.92e-06	7.48e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—APOA1—atherosclerosis	5.91e-06	7.46e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PIK3CG—atherosclerosis	5.39e-06	6.81e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PPARG—atherosclerosis	5.21e-06	6.57e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—INS—atherosclerosis	5.11e-06	6.45e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—ALB—atherosclerosis	4.68e-06	5.91e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—NOS3—atherosclerosis	4.48e-06	5.65e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—PTGS2—atherosclerosis	4.1e-06	5.17e-05	CbGpPWpGaD
Dorzolamide—CYP2C9—Metabolism—AKT1—atherosclerosis	3.12e-06	3.94e-05	CbGpPWpGaD
Dorzolamide—CYP3A4—Metabolism—AKT1—atherosclerosis	2.06e-06	2.6e-05	CbGpPWpGaD
